Ankit Ganeshpurkar
7PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 11, 2024
Machine learning-based virtual screening and molecular modelling studies for identification of butyrylcholinesterase inhibitors as anti-Alzheimer's agent.Ankit Ganeshpurkar, Likhit Akotkar, Devendra Kumar
|Dec 28, 2022
Identification of potential death-associated protein kinase-1 (DAPK1) inhibitors by an integrated ligand-based and structure-based computational drug design approach.Powsali Ghosh, Ravi Singh, Ankit Ganeshpurkar
|Jul 21, 2022
Pharmacophore-based virtual screening, molecular docking and molecular dynamics simulations study for the identification of LIM kinase-1 inhibitors.Ravi Singh, Ankit Vyankatrao Pokle, Powsali Ghosh
|Jun 16, 2022
Identification of sulfonamide-based butyrylcholinesterase inhibitors using machine learning.Ankit Ganeshpurkar, Ravi Singh, Devendra Kumar
|May 13, 2022
Multiple 3D-QSAR modeling, e-pharmacophore, molecular docking, and in vitro study to explore novel AChE inhibitors.Srabanti Jana, Ankit Ganeshpurkar, Sushil Kumar Singh
|Oct 26, 2021
Development of homology model, docking protocol and Machine-Learning based scoring functions for identification of Equus caballus's butyrylcholinesterase inhibitors.Ankit Ganeshpurkar, Ravi Singh, Devendra Kumar
Pageof 2
